Recent News
Really Too. Open Table, August 2020
The scary outcome that’s become increasingly a reality for certain Covid-19 patients. In NYT this morning. Bring on the ifenprodil! (Disclosure: Long Algernon) By Denise …
New from Tony Pullen on Altum/BetterLife
CEO Ahmed Douroudian, PhD Covid Canada Revisited by Tony Pullen Dear readers, many of you will recall that I became involved with a company called …
Readers Write: Can NervGen Restore My Brother-in-Law’s Heath? A Narrative of Plight and Hope by Rebecca Adams
Jon, the author’s brother-in-law. Lonely are the brave. Readers Write: Can NervGen Restore My Brother-in-Law Jon’s Health? A Narrative of Plight and Hope by Rebecca …
Bucky Bucks? Highbrow Nanocarbon Chemistry May Be a High-Dollar Investing Opportunity for BioPub Readers
“When I am working on a problem, I never think about beauty but when I have finished, if the solution is not beautiful, I know …
NervGen Announces Capital Raise
William Radvak, Executive Chairman NervGen Pharma ($NGENF) BioPub’s Best Board Chairman in Biotech, 2020 NervGen announced today plans for a capital raise commencing immediately. Readers who …
Special Report: Should $KNWN Investors Swim For Shore?
Ron Erickson, JD….wearing no life jacket Chairman and Co-Founder Know Laboratories ($KNWN) The Pub has been dyspeptic since, late last week, longtime New Jersey reader …
LexaGene Back on BioPub TV Friday, 24 July at Noon Eastern
LexaGene CEO and Founder Jack Regan, PhD Jack’s Back! Along with LexaGene President Daryl Rebeck About a year has passed since BioPub launched coverage of the this …
A Dockside Chat with Antibe CEO Dan Legault, Friday, 10 July, Noon EST
Antibe Therapeutics CEO Dan Legault Though Legault remains on Covid19 quarantine on his farm north of Toronto, plenty of water has flowed beneath the bridge …
Really. Open Table July 2020
Director and Actor “Reality is merely an illusion, albeit a very persistent one.” ― Albert Einstein “Reality exists in the human mind, and nowhere else.” …
Welcome to July: Mid-Year Ruminations of a Self-Amused (Perchance Bemused) Editor by Jonathan Coulborn
BioPub Editor Jonathan Coulborn, MBA by Jonathan Coulborn I intended a blurb about the state of my portfolio that waxed, as good rumination will, into a …
Siyata: A Special Situations Indirect COVID19 Play by Tony Pullen
BioPub Canadian Editor at Large Tony Pullen [Our Canadian colleague Tony Pullen approached us with this unusual investing opportunity, one that we admit is not …
BioPub Chemist JimT Muses on the Hydrophobic Effect
[Editor’s note: hydrophilic and hydrophobic molecules have aversion to each other, but explaining why…indeed, explaining what it MEANS to be hydrophilic or hydrophobic, much less …
Join The BioPub
Community
Register now and gain access to our medical and science forums.
BIOPUB Webcasts
BioPub is the only biotech investing forum regularly providing readers top-tier unfettered live access to biotech executives…in the form of live webcasts once or twice weekly with new companies that have evoked editorial attention and established companies in the BioPub stable of investments. Our copyrighted, exclusive webcasts are recorded and archived on this website and sometimes on our youtube channel. Have a question for which the answer will influence your investment decision? Show up and ask.
Editor-in-Chief KSS, MD, PhD, holds a monthly members-only “townhall” online gathering presenting candid views on the state of investments covered at BioPub, and new investing ideas. He’s happy to take your questions live.
BIOPUB Webcasts
BioPub is the only biotech investing forum regularly providing readers top-tier unfettered live access to biotech executives…in the form of live webcasts once or twice weekly with new companies that have evoked editorial attention and established companies in the BioPub stable of investments. Our copyrighted, exclusive webcasts are recorded and archived on this website and sometimes on our youtube channel. Have a question for which the answer will influence your investment decision? Show up and ask.
Editor-in-Chief KSS, MD, PhD, holds a monthly members-only “townhall” online gathering presenting candid views on the state of investments covered at BioPub, and new investing ideas. He’s happy to take your questions live.
Editor-in-Chief KSS, MD, PhD, holds a monthly members-only “townhall” online gathering presenting candid views on the state of investments covered at BioPub, and new investing ideas. He’s happy to take your questions live.
BioPub
a publication of Helixir Media, LLC
-
Founders (2013)
KSS, MD, PhD (New York) Alan Harris (London)
-
Editors
KSS, MD, PhD, FACP: Editor-in-Chief and Publisher
Jonathan Coulborn, MBA: Editor
Kristine Dorward, MBA: Senior Associate Editor
cw99, MD: Associate Editor
Paul Harte: Associate Editor
OneMdcn: Associate Editor
-
- Cleveland: Contributing Editor
- Glenn Newberry: Editor At Large
- Cleveland: Contributing Editor
EDITORIAL BOARD
- Jonathan Coulborn: MBA, Chairman
- Tom Nall: Tampa, Florida
- cw99, MD: Austin, TX
- KSS, MD, PhD: ex officio
-
Paul Harte: San Francisco, CA
Kristine Dorward, MBA: Montreal - Melanie, MS: New York, NY
